0001462573-14-000002.txt : 20140619 0001462573-14-000002.hdr.sgml : 20140619 20140619112459 ACCESSION NUMBER: 0001462573-14-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140619 DATE AS OF CHANGE: 20140619 EFFECTIVENESS DATE: 20140619 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Asterias Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001572552 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 461047971 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-219477 FILM NUMBER: 14929749 BUSINESS ADDRESS: STREET 1: 230 CONSTITUTION DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 510-521-3390 MAIL ADDRESS: STREET 1: 230 CONSTITUTION DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 D 1 primary_doc.xml X0707 D LIVE 0001572552 Asterias Biotherapeutics, Inc. 230 CONSTITUTION DRIVE MENLO PARK CA CALIFORNIA 94025 510-521-3390 DELAWARE BioTime Acquisition Corporation None Corporation true 2012 PEDRO LICHTINGER 230 CONSTITUTION DRIVE MENLO PARK CA CALIFORNIA 94025 Executive Officer ALFRED D KINGSLEY 150 E. 57th STREET SUITE 24E NEW YORK NY NEW YORK 10022 Director RICHARD T LeBUHN 724 FIFTH AVENUE 9TH FLOOR NEW YORK NY NEW YORK 10019 Director ROBERT W PEABODY 230 CONSTITUTION DRIVE MENLO PARK CA CALIFORNIA 94025 Executive Officer Director JUDITH SEGALL 230 CONSTITUTION DRIVE MENLO PARK CA CALIFORNIA 94025 Director MICHAEL D WEST 230 CONSTITUTION DRIVE MENLO PARK CA CALIFORNIA 94025 Executive Officer Director Biotechnology $1 - $1,000,000 06b false 2014-06-09 false true true true false 0 3276000 936000 2340000 Includes 200,000 shares of common stock sold for $468,000 in cash; 200,000 shares of common stock granted under the issuer's Equity Incentive Plan and valued at $468,000; and options to purchase 1,000,000 shares of common stock at $2.34 per share. false 1 0 0 468000 true Represents estimated value of common stock granted to executive under Equity Incentive Plan. false Asterias Biotherapeutics, Inc. /s/ Robert W. Peabody Robert W. Peabody Chief Financial Officer 2014-06-18